Cleared Traditional

K983309 - SENSITITRE 19 - 24 HOUR SUSCEPTIBILITY PLATES WITH LEVOFLOXACIN

K983309 is an FDA 510(k) clearance for SENSITITRE 19 - 24 HOUR SUSCEPTIBILITY ..., manufactured by Accumed Intl., Inc.. The device is a Class 2 Microbiology device with product code LTT cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K983309 · Accumed Intl., Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1998
Decision
84d
Days
Class 2
Risk

K983309 is an FDA 510(k) clearance for the SENSITITRE 19 - 24 HOUR SUSCEPTIBILITY PLATES WITH LEVOFLOXACIN. Classified as Panels, Test, Susceptibility, Antimicrobial (product code LTT), Class II - Special Controls.

Submitted by Accumed Intl., Inc. (Westlake, US). The FDA issued a Cleared decision on December 14, 1998 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1640 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Accumed Intl., Inc. devices

FDA 510(k) Submission Details - K983309

510(k) Number K983309 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 1998
Decision Date December 14, 1998
Days to Decision 84 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d faster than avg
Panel avg: 102d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LTT Device Classification - Class 2, Special Controls

Product Code LTT Panels, Test, Susceptibility, Antimicrobial
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LTT Panels, Test, Susceptibility, Antimicrobial

All 49
Devices cleared under the same product code (LTT) and FDA review panel - the closest regulatory comparables to K983309.
PASCO MIC AND MIC/ID PANELS
K001721 · Pasco Laboratories, Inc. · Aug 2000
DRIED GRAM-POSITIVE MIC/COMBO PANELS
K993102 · Dade Microscan, Inc. · Dec 1999
SENSITITRE 18-24 HOUR SUSCEPTIBILITY PLATES WITH GREPAFLOXACIN
K983306 · Accumed Intl., Inc. · Dec 1998
PASCO MIC AND MIC/ID PANELS
K973317 · Pasco Laboratories, Inc. · Nov 1997
DRIED GRAM-POSITIVE MIC/COMBO PANELS
K972799 · Dade Microscan, Inc. · Oct 1997
DRIED GRAM-NEGATIVE AND GRAM-POSITIVE MIC/COMBO PANELS
K962150 · Dade Intl., Inc. · Aug 1996